TY - JOUR
T1 - Accelerative Solid-State Oxidation Behaviour of Amorphous and Partially Crystalline Venetoclax
AU - Afonso Urich, Jesús Alberto
AU - Marko, Viktoria
AU - Boehm, Katharina
AU - Werner, Bernd
AU - Zangger, Klaus
AU - Saraf, Isha
AU - Paudel, Amrit
AU - Kushwah, Varun
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2024.
PY - 2024/6
Y1 - 2024/6
N2 - There is a growing focus on solid-state degradation, especially for its relevance in understanding interactions with excipients. Performing a solid-state degradation of Venetoclax (VEN), we delve into VEN's stability in different solid-state oxidative stress conditions, utilizing Peroxydone™ complex and urea peroxide (UHP). The investigation extends beyond traditional forced degradation scenarios, providing insights into VEN's behavior over 32 h, considering temperature and crystallinity conditions. Distinct behaviors emerge in the cases of Peroxydone™ complex and UHP. The partially crystalline (PC-VEN) form proves more stable with Peroxydone™, while the amorphous form (A-VEN) shows enhanced stability with UHP. N-oxide VEN, a significant degradation product, varies between these cases, reflecting the impact of different oxidative stress conditions. Peroxydone™ complex demonstrates higher reproducibility and stability, making it a promising option for screening impurities in solid-state oxidative stress scenarios. This research not only contributes to the understanding of VEN's stability in solid-state but also aids formulators in anticipating excipient incompatibilities owing to presence of reactive impurities (peroxides) and oxidation in the final dosage form. Graphical Abstract: (Figure presented.)
AB - There is a growing focus on solid-state degradation, especially for its relevance in understanding interactions with excipients. Performing a solid-state degradation of Venetoclax (VEN), we delve into VEN's stability in different solid-state oxidative stress conditions, utilizing Peroxydone™ complex and urea peroxide (UHP). The investigation extends beyond traditional forced degradation scenarios, providing insights into VEN's behavior over 32 h, considering temperature and crystallinity conditions. Distinct behaviors emerge in the cases of Peroxydone™ complex and UHP. The partially crystalline (PC-VEN) form proves more stable with Peroxydone™, while the amorphous form (A-VEN) shows enhanced stability with UHP. N-oxide VEN, a significant degradation product, varies between these cases, reflecting the impact of different oxidative stress conditions. Peroxydone™ complex demonstrates higher reproducibility and stability, making it a promising option for screening impurities in solid-state oxidative stress scenarios. This research not only contributes to the understanding of VEN's stability in solid-state but also aids formulators in anticipating excipient incompatibilities owing to presence of reactive impurities (peroxides) and oxidation in the final dosage form. Graphical Abstract: (Figure presented.)
KW - degradation products
KW - oxidative stress study
KW - pharmaceutical stability
KW - solid state degradation
UR - http://www.scopus.com/inward/record.url?scp=85193351353&partnerID=8YFLogxK
U2 - 10.1208/s12249-024-02832-8
DO - 10.1208/s12249-024-02832-8
M3 - Article
C2 - 38750299
AN - SCOPUS:85193351353
SN - 1530-9932
VL - 25
JO - AAPS PharmSciTech
JF - AAPS PharmSciTech
IS - 5
M1 - 114
ER -